Results 141 to 150 of about 5,014 (197)

[Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru]. [PDF]

Rev Chilena Infectol, 2013
Alave J, Paz J, González E, Campos M, Rodríguez M, Willig J, Echevarría J.   +6 more
europepmc   +1 more source

Efecto de la terapia antirretroviral sobre el perfil lipídico de pacientes con Sida en Maracaibo, estado Zulia, Venezuela

Kasmera, 2010
: A prospective study was carried out to determine the effect of antiretroviral therapy on the lipid profile in a population of 50 patients with AIDS who received their first antiretroviral drug treatment in the HIV-AIDS clinic at the Maracaibo ...
Soto Isabel, Villalobos-B María, Villalobos-P Rafael   +2 more
doaj  

Generation of Mesenchymal Cell Lines Derived from Aged Donors. [PDF]

Int J Mol Sci, 2021
Piñeiro-Ramil M, Sanjurjo-Rodríguez C, Rodríguez-Fernández S, Castro-Viñuelas R, Hermida-Gómez T, Blanco-García FJ, Fuentes-Boquete I, Díaz-Prado S.   +7 more
europepmc   +1 more source

Terapia antirretroviral directamente observada en mujeres privadas de libertad Directly observed anti-retroviral therapy amongst female inmates

Revista Española de Sanidad Penitenciaria, 2009
Objetivos: La adherencia al tratamiento antirretroviral de alta eficacia (TARV) se considera el gold standard para el éxito del mismo. Para mejorar la adherencia en persona privadas de libertad viviendo con VIH-Sida, se propuso la utilización del ...
L. De Carolis, C. Wainstein
doaj  

Atividade física e lipodistrofia em portadores de HIV/AIDS submetidos à terapia anti-retroviral

, 2014
Após a introdução da terapia anti-retroviral altamente ativa (TARV), houve significativo aumento da sobrevida e melhora da qualidade de vida de indivíduos portadores de HIV, porém, esses tratamentos têm efeitos colaterais que podem causar transtornos para seus usuários, dentre os quais, a lipodistrofia.
openaire   +1 more source

[Triglyceride-glucose index changes after one year of antiretroviral therapy]. [PDF]

Rev Med Inst Mex Seguro Soc
Pérez-Pedraza EE, Albarrán-Sánchez A, Ramírez-Rentería C.   +2 more
europepmc   +1 more source

Therapy free of cells vs human mesenchymal stem cells from umbilical cord stroma to treat the inflammation in OA. [PDF]

Cell Mol Life Sci, 2022
Morente-López M, Mato-Basalo R, Lucio-Gallego S, Silva-Fernández L, González-Rodríguez A, De Toro FJ, Fafián-Labora JA, Arufe MC.   +7 more
europepmc   +1 more source

Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. [PDF]

J Transl Med
Pisani I, Melita G, de Souza PB, Galimberti S, Savino AM, Sarno J, Landoni B, Crippa S, Gotti E, Cuofano C, Pedrini O, Capelli C, Matera G, Belotti D, Cesana S, Cabiati B, Quaroni M, Colombo V, Mazza M, Vergani B, Gaimari A, Nicolini F, Tazzari M, Bocchini M, Serafini M, Rambaldi A, Rambaldi B, Dastoli G, Biondi A, Gaipa G, Introna M, Golay J, Tettamanti S.   +32 more
europepmc   +1 more source

Highlights in HIV 2022-2024. [PDF]

Rev Esp Quimioter
Núñez Orantos MJ.
europepmc   +1 more source

Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage : a new tool for cartilage pathophysiology studies. [PDF]

Bone Joint Res, 2023
Piñeiro-Ramil M, Sanjurjo-Rodríguez C, Rodríguez-Fernández S, Hermida-Gómez T, Blanco-García FJ, Fuentes-Boquete I, Vaamonde-García C, Díaz-Prado S.   +7 more
europepmc   +1 more source